logo
My Favorite Do-It-All Multitool Is 15% Off for the Final Day of Amazon's Prime Day Sale

My Favorite Do-It-All Multitool Is 15% Off for the Final Day of Amazon's Prime Day Sale

CNET11-07-2025
Amazon Prime Day deal: This 12-in-1 multitool from Gerber has a great deal for the last day of the Amazon Prime Day sale. The red version is $25 or 15% off its regular price and is the perfect addition to an emergency bag or for getting things done around the house. There's currently no deal on the black or green versions.
I have always liked DIY-ing my way around things, but before I moved to the San Francisco Bay Area, keeping an emergency go bag in the house wasn't something I ever worried about. But now I live less than a mile from the fault that earthquake experts say is the region's most dangerous. And among the most frequently asked questions in my house is, "Did you feel that?"
However, natural disasters don't issue a prior warning, so my family and I have created an emergency plan for when the need arises: We keep our car fueled up, we have our portable chargers topped up and at the ready and we all know how to shut off our gas. But maybe the most important prep work we've done is to put together an emergency go bag, also known as a bug-out bag. One item I've included in my go bag is a multitool by Gerber that includes pliers, scissors, screwdrivers, wire cutters, as well as a knife.
You can drop a lot of money on a multitool, and some of those more expensive models are worth it. But because I wanted to buy more than one of these -- since my kids could always use one too -- both price and weight were important to me, which is why I chose the Gerber Dime 12-in-1 Mini multitool.
Priced at about $30, this multitool is always worth grabbing, whether it's on sale or not. Below, I'll explain why I like this tool so much. For more mainstays of the go bag, here are our favorite power banks for iPhones and the best portable solar panels.
Hey, did you know? CNET Deals texts are free, easy and save you money.
Where this multitool fits into my emergency preparedness plans
In addition to having bug-out bags at the ready, we keep an extensive earthquake kit in a big toy chest. With this big kit -- called a stay box -- weight isn't really an issue, and we can store enough food, water and whatever else we need to make it through a few days or even weeks. But in a go bag, each item has to be portable and essential, because weight adds up quickly. (This is the mini lantern I went with.) The Gerber Dime 12-in-1 Mini weighs just a few ounces and fits into the palm of my hand when it's folded up.
Gerber Dime 12-in-1 Mini multitool specs
Material: Stainless steel
Stainless steel Dimensions when open: 5.5 x 4 x 0.6 inches
5.5 x 4 x 0.6 inches Dimensions when closed: 5.5 x 2.75 x 0.6 inches
5.5 x 2.75 x 0.6 inches Weight: 2.2 ounces
2.2 ounces Included tools: Pliers, wire cutter, tweezers, small and medium-size flat-head screwdrivers, bottle opener, retail package opener, plain-edge blade, scissors, fine and coarse files, lanyard/key ring
Best Prime Day Kitchen Appliance Deals
Score some of the best discounts of the year on top kitchen tech during Prime Day, and our shopping experts have rounded up the only deals worth taking seriously this year.
See Now
Why the Gerber Dime Mini makes a great gift
This is also a great tool to have in your car or your desk drawer at work.
Gerber
Gifting this multitool may seem overly practical, but there will eventually be a time that it will come in handy for anyone. Plus, you really can't beat its price compared to some of the competition out there. This is perfect for your handy friends who could always use another gadget for fixing things or someone building out their emergency bags.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT
Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT

Yahoo

time19 minutes ago

  • Yahoo

Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT

Exelixis, Inc. (NASDAQ:EXEL) is one of the most profitable biotech stocks to invest in now. On July 22, Morgan Stanley analyst Sean Laaman maintained a Buy rating on Exelixis, Inc. (NASDAQ:EXEL) and set a price target of $48.00. A team of scientists in lab coats surrounded by pharmaceuticals and medical equipment, researching a life-saving oncology-focused biotechnology. The analyst reasoned that Exelixis, Inc. (NASDAQ:EXEL) recently updated its 2025 revenue guidance, increasing it to a $2.25-2.35 billion range after the higher-than-expected sales of Cabo. He attributed this optimistic outlook to the persistent demand growth and new patient starts in first-line renal cell carcinoma (1L RCC). Laaman also stated that Exelixis, Inc. (NASDAQ:EXEL) reported that it may update its guidance further as the NET launch progresses and additional revenue opportunities become clearer. Exelixis, Inc. (NASDAQ:EXEL) discovers, develops, and commercializes new medicines for difficult-to-treat cancers. Its product portfolio includes cabometyx, cometriq, and cotellic. While we acknowledge the potential of EXEL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

The Open Group Launches The Open Group Open Digital Transformation™ Forum
The Open Group Launches The Open Group Open Digital Transformation™ Forum

Yahoo

time19 minutes ago

  • Yahoo

The Open Group Launches The Open Group Open Digital Transformation™ Forum

Standards body aims to spur faster, more effective transformation initiatives SAN FRANCISCO, July 28, 2025--(BUSINESS WIRE)--The Open Group, the vendor-neutral technology consortium, has today announced the formation of The Open Group Open Digital Transformation™ Forum (ODXF). This new initiative will support enterprise Digital Transformation by developing and popularizing pragmatic, open standards in this increasingly valuable and challenging space. By establishing clear guidelines for Digital Transformation initiatives and enabling cross-industry collaboration to share insights and best practices, ODXF aims to ensure that a greater share of Digital Transformation investment globally delivers effective returns on investment and measurably positive impacts on cultural, workforce, and technological changes. "The vast majority of enterprises today are engaged in Digital Transformation initiatives, with significant global spend in Digital Transformation," commented Rashed Al-Yami, Governing Board Member of The Open Group and Manager Digital Platforms & Architecture Design Division at Aramco. "By developing open standards through vendor-neutral collaboration, ODXF can influence the Digital Transformation agenda towards more rigorous and successful practices." Key focus areas for ODXF include developing standardized frameworks for Digital Transformation initiatives, ensuring consistency, and producing reference architectures which organizations can incorporate in order to make their own Digital Transformation journeys more agile and responsive. The Forum will also collaborate on establishing a body of knowledge, which incorporates a range of documents designed to help users operationalize the standard, as well as ultimately delivering a certification program for practitioners to demonstrate that they understand and can apply best-in-class approaches to Digital Transformation. "Digital Transformation is not a new term, but the emergence of a range of disruptive technologies, from AI to quantum computing, has made it more urgent than ever for businesses to find a clear guiding path towards proven approaches to this challenge," said Steve Nunn, President and CEO of The Open Group. "Our track record of bringing industry stakeholders together in a neutral, collaborative space means that The Open Group is well placed to add value to one of the world's major areas of investment." To learn more about The Open Group Open Digital Transformation Forum, please visit here. About The Open Group The Open Group is a global consortium that enables the achievement of business objectives through technology standards and open source initiatives by fostering a culture of collaboration, inclusivity, and mutual respect among our diverse group of 900+ memberships. Our Membership includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries. View source version on Contacts Media contact Monika BoudovaHotwire for The Open GroupUKOpengroup@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)
RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)

Yahoo

time19 minutes ago

  • Yahoo

RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)

Abbott Laboratories (NYSE:ABT) ranks among the . RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott's strong single-digit revenue and double-digit EPS growth potential as examples of its ability to provide top-tier financial growth in the medical technology industry. According to RBC Capital's intra-quarter checks, Abbott Laboratories (NYSE:ABT) maintains positive healthcare utilization in Q2. Moreover, Abbott's diabetes brand, which has been attracting a lot of investor interest, was one of the several growth catalysts mentioned in the firm's report. The less elective nature of Abbott's medical device portfolio was also mentioned by RBC as a benefit. RBC Capital's sustained belief in Abbott Laboratories (NYSE:ABT) as the best-performing large cap in its coverage year-to-date is bolstered by other positives such as business momentum in diabetes care, favorable trends in diagnostics, stability in nutrition, and strength in established pharmaceuticals. Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store